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Human immunodeficiency virus 1 (HIV1) is a retrovirus that has many similari-
ties with members of the nontransforming and cytopathic animal lentivirus family
(1) . These viruses, includingHIV1, cause slowly progressive, chronic, and, in some
instances, fatal diseases in their hosts. The time from initial viral infection to clini-
cally observed symptoms of disease is usually measured in years (2) . Elucidation
of the viral life cycle during the subclinical phase of infection is critical in gaining
a clearer understanding of the pathophysiology ofAIDS . Several studies have sug-
gested that a persistent state of latent or chroniclow level productive infection exists
in fresh and cultured cells (3-7) . Thesedata imply that viral latencycanbe a compo-
nent ofHIV infectivity. The mechanisms involved in developing these latent or re-
stricted states of HIV expression are not well understood .
Animal lentiviruses show a tropism for cells of the monocyte/macrophage lineage
during viral latency and persistence (8) . There isnowsubstantial evidence suggesting
that the monocyte/macrophage also serves as a reservoir for HIV infection (9) . Fresh
monocytes can be infected in vitro with HIV . Also, HIVcanbe cultured from mono-
cytes obtained from blood andorgans ofpatients infected with HIV(9) . In the brain,
the macrophage is the major infected cell type and is associated with the develop-
ment of neurologic symptoms seen in AIDS patients (10, 11).
This study was initiated to develop HIV-infected monocyte cell lines that could
be used to understand mechanisms ofviral latency and restricted low level chronic
expression . THP-1, derived from apatient with acute monocytic leukemia, possesses
morphologic, histochemical, phenotypic, and functional properties of monocytes (12,
13). Analysis ofTHP-1 cultures after an initial productive HIV infection revealed
THP-1 cultures with either latent or restricted HIV expression as well as cultures
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remaining productively infected. In cells with restricted HIV expression, viral ex-
pression is negatively regulated in such a manner as to escape immune surveillance
and still be capable of transmitting virus to T cells. In cells with latent virus, no
viralexpression is seen but infectious virus can be activated by a mechanism distinct
from the upregulation of viral expression in cells with restricted expression.
Materials and Methods
Cell Lines.
￿
THP-1 cellswere maintained in RPMI with 10'/o FCS, penicillin (100 hg/ml),
streptomycin (100 kg/ml), and glutamine(300 t~g/ml); cellswere subcultured 1 :5 every4-5 d.
HELA and murine CB2MX3 cells producing HIV-1 tat, obtained from G. Pavlakis (BRI,
Frederick, MD), were grown as monolayercultures in DMEM as previously described (14).
VirusesandInfections.
￿
Allviruseswere isolated from PBMCs. HIV-1 strain BP-1 wasgrown
in HUT78 (15), strain ADA was grown in U-937 (16), and HIV-2 Rod was grown in CEM
(17). 107 THP-1 cells in log phase growth were infected with 5 x 105 tissue culture infec-
tious doses at a 50% endpoint (TCID5)' harvested from cell-free supernatants of each virus
after 5 d ofgrowth. Infections were done in 1 ml serum-free RPMI with 2Ag/mlofpolybrene
for 1-2 h at 37°C in a shaking water bath. Cells were washed twice to remove unabsorbed
virus and subcultured for growth. For the multiplicity of infection (MOI; number of TCID5o
U/cell) study, concentrated viral stocks, made usinga tangential flow Millitan Apparatus(Mil-
lipore Continental Water Systems, Bedford, MA), were used to give the indicated MOI.
Virus Detection.
￿
Viral p24 antigen was determined on tissue culture supernatants or cell
pelletslysed with 1% Triton X-100by ELISA (CellularProducts, Inc., Buffalo, NY). As pre-
viously shown, HIV p24 ELISA kits do not discriminate between HIV-1 and HIV-2 p24
(18). TCID5o was determined using microtiter wells of HUT-102B2 with serial dilutions of
cell-free virus. Electron micrographs of HIVinfected cells were prepared by OS04-fixed, rap-
idly dehydrated THP-1 or HUT-102B2 cells and embedded in epoxy resin using standard
procedures. Thin sections were mounted, stained with uranyl acetate and lead citrate, and
viewed in amicroscope (H-7000; Hitachi, Tokyo, Japan) as previously described (1). Forsyn-
cytia formation, 200 infected THP-1 cells were incubated with 106 HUT-102132 cells. HIV-1-
induced syncytia were recorded by microscopic analysis. Reversetranscriptase (RT) activity
was measured in cell supernates pelleted by high-speed centrifugation using poly(rA)-oligo
(dT12-18) template primer, 20 mM Mg2' as cofactor, and appropriate deoxynucleotide
triphosphates as previously described (19). Results were adjusted to cpm of [3H]TTP-in-
corporated [3H]/ml.
Phenotypic Analysis ofHIVInfected THRL
￿
Cytofluorometric analysis wasperformedas de-
scribed (15). Cells washed in PBS were fixed in -10°C absolute methanol for intracellular
p24 antigen determination. The cells were not fixed for all other assays. mAbs used were
directed against HIV p24, HIV gp 160:41, and HIV-1 gp 120(CellularProducts, Inc.). Other
monoclonals againstLeu-3A (CD4), Leu-2 (CD8), Leu-M3 (CD14), andHLA-DR were pur-
chased from Becton Dickinson & Co. (Sunnyvale, CA).
FunctionalAssays.
￿
Forviral-mediated cell cytotoxicity, HIV-infected cultures aretested ei-
ther by titering out5-d supernatants against 10,000 MT-2 cellsperwell in around-bottomed
96-well plate or by coculturing with infected cells. After various days of incubation, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) is used to measure in vitro
growth by cell-mediated reduction oftetrazolium (20). The OD at 540nm is directly propor-
tional to the number of viable cells. Macrophage functional assays were performed plus or
minus PMA (50 ng/ml) treatment for 24 h. Phagocytosis was performed by incubating 106
cells with 100 lcl zymosan for 1 h. Cell smears were then stained with Jenners, and 1,000
cellswere examined microscopically. For accessory cell function, monocyte-free lymphocytes
obtained by elutriation were separated into T4 and T8 populations as previously described
(15). THP-1- and HIV-infected THP-1 irradiated at 8,000 rad were added to 105 T8 cells
in a culture volume of 0.2 ml at serial dilutionsofTHP-1 cellswith or without Con A(5 ttg/ml).
' Abbreviations used in this paper: LGL, large granular lymphocyte; LTR, long terminal repeat; MOI,
multiplicity of infection; PCR, polymerase chain reaction; RT, reverse transcriptase; TCID5o, tissue
culture infectious dose 50% endpoint.MIKOVITS ET AL.
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Stimulated cultures were incubated 72 h at 37'C. MTT assay was performed as previously
described (20).
NK Cytotoxicity Assay.
￿
For cytotoxicity assays, large granular lymphocytes (LGL) were
purified on Percoll gradients and activated overnight at 105 cells/ml with 100 U of rIL-2 (Bio-
gen, Cambridge, MA) and cytotoxicity assays performed as previously described (15). A 6%
increase in isotope release, above baseline, was consistently statistically significant at p <0.05
(student's t test).
Analysis ofViralNucleic Acids in THP1 Cells.
￿
Preparation oftotal cellular RNA for Northern
transfer experiments was done by the guanidine thiocyanate CsCl gradient method. Poly-
adenylated RNA was prepared by oligo(dT)-cellulose column chromatography. RNA pellets
were twice precipitated with ethanol and quantitated by absorbance at 260 nM. Ethidium
bromide staining was used to equalize amounts ofnucleic acids. After equilibration, the RNAs
were separated on 0.9% agarose/formaldehyde gels and blotted onto nitrocellulose. Northern
blots were probed by primer extension of DNA fragments of the HIV-1 strain HXB2 (21).
The probes were used at a concentration of 4 x 10'' cpm/ml of dCTP['2]-labeled pHXBA11
(a gift of George Pavalakis, Bionetics Research Inc., Frederick Cancer Research Facility,
Frederick, MD). Blots were prehybridized and hybridized at 42°C for 24 h each. Hybridiza-
tion and washings were done as previously described (22, 23).
Long Terminal Repeat (LTR)-directed NuclearRun-on Competition Experiments.
￿
Analysis ofRNA
transcripts was carried out by nuclear transcription run-on assay. Adaptions of the method
of Greenberg and Ziff (22) were made as previously described (23). The ;`2P-labeled RNA
was recovered by treating with a final concentration of 0.2 M NaOH for 10 min on ice, neu-
tralized by acid-free Hepes to a final concentration of 0.24 M. This purified labeled RNA
was hybridized at 65°C for 30 h to purified HIV-1 LTR fragment immobilized on nitrocellu-
lose. A recombinant construct pL3CAT consisting of a Barn HI-Hind III fragment of HIV-1
(nucleotides -1068 to +83), which contains the HIV-1 LTR promoter as well as downstream
TAR sequences (14), was used to isolate template DNA. pL3CAT was digested with Kpn
1-Hind III, purified on a 1% low melting agarose gel; phenol was extracted and washed with
70% ethanol, and then the dried template was used in the assay. Hybridizations and washings
were done as previously described (22, 23).
Mobility ShaftAssay.
￿
For binding assays, the plasmid pL3-CAT (14) was digested with Hind
III, dephosphorylated with CIAP, ethanol precipitated, and then 5'-labeled with 7-["PIATP
and T4 polynucleotide kinase. The labeled fragment was digested again with Eco RV. The
199-bp fragment was gel purified and recovered as described above. The assay used was a
slight modification of the procedure of Kadonaga et al. (24). The assay was done in 20-pl
reaction volume containing 20 mM Hepes (pH 7 .6), 60 mM KC1, 10% glycerol, 0.5 mM
EDTA, 0.5 mM DTT, 1 wg poly dl-poly c1C, 0.05% NP-40,50,000 cpm of end-labeled DNA
probe (Eco RV-Hind III of HIV-1 LTR), and nuclear extracts at 5 or 10 pg protein. Nuclear
extracts were prepared by the method of Parker and Topol (25). For competition studies,
a 25-fold excess of the same unlabeled DNA fragment was added to the reaction mixture,
In mixing experiments, a ratio of one part of extract for inhibition to four parts extract to
be inhibited was used with the protein content held constant at either 5 or 10 ug. The reaction
mixture was incubated at 30°C for 1 h and then subjected to electrophoresis at 10 V/cm through
a 4% polyacrylamide (nondenaturing) gel in Tris-EDTA-Borate buffer.
Polymerase Chain Reaction (PCR) Analysis of RNA Products in HIV-1-infected THP-1.
￿
1 kg of
DNA or RNA from infected or uninfected cells was amplified as previously described (26)
in reaction mixtures containing primer pairs specific to HIV-1 gag region of the HIV-1 viral
genome. 50 pmol of each primer was used. For detection of RNA, an additional step of re-
verse transcription of RNA to DNA by avian myeloblastosis virus RT was incorporated where
the amplification primer initiated the reverse transcription (26). PCR products were ana-
lyzed by hybridization with specific probes spanning the region between primer pairs fol-
lowed by analysis on polyacrylamide gels where the expected radiolabeled band for gag is
114 by (26).
Results
Differential Expression ofHIV after Infection of THP-1 Cells.
￿
An acute infection of
THP-1 cells was established by incubating HIV-1 (strain BP-1) at an MOI of 0.051708
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with cells in the log phase of growth. In each experiment, productive infection as
measured by extracellular virus was not detected at day 7, butwas detected between
day 14 and 17. Extracellular virus was detected in media by four assays: presence
ofp24 core antigen, RT, viral-mediated T cell cytolysis, and syncytia formation(Table
I). Phenotypic analysis ofthe cells showed that monocyte surface antigens, such as
CD14 (Leu-M3), were unaffected by HIV1, while CD4 antigen (Leu-3A) could no
longer be detected on the cell surface, presumably blocked by the binding ofHIV
virions (Fig. 1 b). Also, 30-40% of the cells contained surface antigens recognized
by anti-gp 160:41 (Fig. 1 b).
In contrast, 45-60 d afterthe onset ofacute infection, entire cultures ofthese pre-
viously productively infected cells produced little or no extracellular virus (Table
I, lines 3, 5, and 8-10). Cell surface analysis showed that CD4 antigen could be
recognized again while the presence of viral antigens could not be detected (Fig.
1, c). Presence of virus as measured by RT, infectivity, T cell cytopathology, and
syncytia formationwas not detected in the media ofthesecells. However, the media
ofsome ofthese cultures contained p24 core antigen at aconcentration of<20 ng/ml,
as compared with 200-500 ng/ml for productive cultures. These cultures remained
HIV infected as shownby increased expression aftertreatment ofthe cells withLPS,
(Table I, line 4) or irradiation (Fig. 1 d). 72 h after activation ofthe cells, extracel-
lular virus, as measured by all thecriteria used, was present and viral antigens could
again be detected on the cells. These data suggested that viral expression was re-
stricted in these cells. In addition, several nonproducer THP-1 cultures remained
nonproducers afteractivation (Table 1). This absence orlow levelofviral production
in infected THP-1 cells was reproducibly seen with two other isolates, HIV-1 ADA,
a monocytoid isolate, and HIV-2 Rod (Table I).
Conditions for Establishing Restricted Viral Production in THR1 Cells.
￿
To better un-
derstand the conditions necessary for the establishment of restricted expression, ex-
periments were done to askthe effect ofMOIon subsequent viralexpression in THP-1
TABLE I
Analysis of HIV-1-infected THP-1 Cells
THP-1 cells were grown and infected with HIV strains at an MOI of 0.05, as described
in Materials and Methods. Analysis of the viral expression was made 60 d post-infection,
as described in Materials and Methods. Values are for at least three separate infections.
Cells were incubated for 48 h with 10 hg of LPS, and viral assays were performed.
Viral
strain
Viral
expression
Syncytia
(percent positive) p24 antigen Viral RT
ng/ml cpm/ml
1. None None 0 0 0
2. BP-1 Producer 2-5 200-500 30-60,000
3. BP-1 Restricted 0 0.5-20 0
4. BP-1 Restricted (LPS)' 1-2 200-500 15-20,000
5. BP-1 Nonproducer 0 0 0
6. BP-1 Nonproducer (LPS) 0 0 0
7 . ADA Producer 5-10 1,500 50-100,000
8. ADA Nonproducer 0 0 0
9. ROD Restricted >1 0.1-100 5-10,000
10. ROD Nonproducer 0 0 0100
1000 1
100 I %POS=9 MEAN=157
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FIGURE 1.
￿
Phenotypic characterization of HIV infection of HIV. FACS analysis using Leu-3a
(CD4), Leu-m3 (CD14), and HIV-1 gp 160:41 was performed as described in Materials and
Methods. (a) Uninfected THP-1; (b) productively infected THP-1; (c) infected THP-1 with no
expression; (d) infected THP-1 with no expression 48 h after irradiation. Antibodies used were
A-CD4, B-CD14, and C-HIV1 gp 160:41. Analysis was performed as described in Materials
and Methods.
cells(Table II). Athigh MOI, productive infection with cell cytotoxicity wasevident
with no restricted expression ofHIV seen. Asthe MOI waslowered, initial produc-
tive infection was followed by development of several cultures with restricted or no
viral expression. Infection ofTHP-1 with HIV-2 Rod resulted in only restricted ex-
pression. This was probably due to notbeing able to obtain aviral preparation with
a higher titer.
Kinetics ofexpression ofp24in THP-1 cellswas also followed after HIV infection.
Until day21, bothproductive and restricted HIVcultures containedthesamenumber
of viral p24-positive cells. However, by day 60, >95To ofthe cells were positive in
the productive cultures, whereas only 32% were positive in the cultures with re-
stricted expression. It seemslikely that restricted HIV-1 expression also leads to de-
creasedviral spread. At no timeafter thedevelopmentofnonproducercultureswere
any cells in these cultures positive for HIV-1 p24 antigen.
Characterization of THR1 Cells with Restricted HIVExpression.
￿
Since little or no de-
tectable extracellularviruswas found insomeHIV-infected THP-1 cultures, the status
ofviral expression was examined in these cells. Highlevels ofviral RNA were found
in the productively infected THP-1 (Fig. 2 A, lane 2) with prominent peaks at the
genomic 9.1-kb size, alongwith subgenomic 4.4- and 2.0-kbmRNAs. However, THP-1
cultures with restricted expression contained markedly less viral RNA (Fig. 2 A,
lane 4) than the productively infected cultures (Fig. 2 A, lane 3) with subgenomic
RNAs of 7.5 and 4.4 kb preferentially accumulating over full-length 9.1-kb RNA
(Fig. 2 B, lane 5). A 7.5-kb RNA species has not been previously reported and its
Z
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TABLE II
Effect of MOI on HIV Infection of THP-1 Cells
* MOI is the number of TCID5o U/cells. THP-1 cells were grown and infected with HIV
strains as described in Materials and Methods.
1 Number of days post-infection that detectable virus was present in extracellular media as
assayed by viral p24 antigen.
Cytolysis and cell death were observed microscopically . Infected cultures of ADA at high
MOI showed complete death.
II Analysis of the restricted viral expression was made 60 d post-infection using the criteria
of no syncytia formation and low or absent extracellular p24, as in Table I. Restricted and
nonproducer cultures are included in total.
presence may be related to the mechanism of restricted expression in these cells.
To our surprise, the nonproducer cultures produced no detectable viral RNA (Fig.
2 A, lane 5) even if60 1~gofpoly(A)+-selected RNA (Fig. 2 B, lane 2) was analyzed,
suggesting that HIV expression in these cellswastrulylatent (i.e., complete absence
of viral expression).
Since some ofthenonproductive culturespossessed viral RNA, the status ofintra-
cellular viral particles was studied by EM. In those cultures with restricted viral ex-
pression, intracellular assembly of numerous viral particles was observed. Most of
the virions were seen within intracytoplasmic vacuoles. Many immature and ma-
ture forms, as well as virions budding into the vacuoles, could be seen. The viral
particles seen on ultrastructural analysis were identical to previous descriptions of
HIV (1). As seenin freshly infectedmacrophages (27), these vacuoles were predomi-
nantly found in the perinuclear golgi region. Surprisingly, few if any extracellular
virions were seen. Approximately 30%. ofthecell sectionswere associated with viral
particles. In cultures with latent infection, no intracellular viral particles or viral
RNA could be detected.
Negative Regulation ofHIVExpression in THP-1 with Restricted Expression.
￿
Since the
accumulation of viral RNA in the HIVrestricted cells is many fold lower than in
the HIV-producingcells(Fig. 2 A), the rate ofviraltranscription wasmeasured using
invitrotranscription directed by the LTR in a nuclearrun-on assay(Fig. 3). Exoge-
nous LTR was added to the in vitro transcription mixture so that initiation and
elongation ofviral RNA could be measured. Nuclei from HELA and uninfected
THP-1 showed a small basal level oftranscription. Nuclei from the THP-1 cellswith
restricted expression showed a small increase in therate oftranscription over control
HELA and uninfected THP-1 (Fig. 3, lane 3), but the transcription was much re-
Viral
strain MOP
Days to
infection) Cytolysis'
No. productive/
no. total
No. restricted))/
no. total
BP-1 10 4 + 10/10 0/10
1 7 +/- 10/10 0/10
0.1 14 - 9/10 1/10
0.01 14-18 - 6/10 4/10
ADA 10 4 + + + 3/3 0/3
1 4 + + 3/3 0/3
0.1 7-10 + 3/3 0/3
0.01 14 +/- 1/3 1/3
ROD 1 14 - 0/2 2/2
0.1 21-24 - 0/2 2/2MIKOVITS ET AL . 1711
FIGURE 2 .
￿
Analysis ofviral nucleic acids in in-
fected THP-1 cells. Northern transfer and hybrid-
izations on total RNA were performed as de-
scribed in Materials and Methods. (a) Lane 1,
uninfected THP-1 ; lane 2, THP-1 productively
infected withHIV-1 BP-1 from a 30-min exposure ;
lane 3, THP-1 productively infected with HIV-1
from a 2-h exposure ; lane 4, THP-1 with restricted
HIV-1 expression from a 2-h exposure ; lane 5,
THP-1 .with latent HIV virus from a2-h exposure .
(b) Lane 1, THP-1 productively infected with
HIV 1, poly(A)' RNA 20 gg ; lane 2, THP-1
with latent HIV virus, poly(A)' RNA 60 Ag ;
lane 3, THP-1 with latent HIV virus 72 h after
5-azacytidine (10AM) treatment ; lane 4, THP-1
with latent HIV-1 virus 72 h after 5-azacytidine
treatment cocultured with HUT102132 for 10 d ;
lane 5, THP-1 with restricted HIV-1 expression .
FIGURE 3 .
￿
HIV -1 LTR-directed nuclear run-on
competition experiments . Analysis ofRNA tran-
scripts was performed by nuclear transcription
run-on assay as described in Materials and Meth-
ods. Unless indicated, reactions contained 75 At
nuclei and 25 lxl buffer . Lane 1, THP-1 nuclei ;
lane 2, HELA nuclei ; lane 3, nuclei from THP-1
cells with restricted HIV-1 (BP-1) expression ; lane
4, nuclei from THP-1 cells productively infected
withHIV 1 ; lane 5, nuclei from productively in-
fected THP-1 (75 Al) and nuclei from THP-1 with
restrictedHIV-1 expression (251x1) ; lane 6, nuclei
from productively infected THP-1 (75 1x1) and
nuclei from THP-1 (251x1) ; lane 7, nuclei from
productively infected THP-1 (75 Al) and nuclei
from THP-1 with latent virus (25 1x1) .1712
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duced from levels of transcription observed using nuclei from productively infected
cells (Fig . 3, lane 4) . To ascertain whether nuclear factors in restricted nuclei were
affecting LTR-directed transcription, nuclei from productively infected cells were
incubated with various mixtures ofnuclei (Fig . 3) . Mixing nuclei ina 1 :4 ratio from
either uninfected THP-1 or THP-1 with latent virus with nuclei from productively
infected THP-1 cells did not affect the rate of transcription (Fig. 3, lanes 6 and 7) .
However, therewas a marked decrease (5-10-fold) in thetranscriptional levelofnuclei
from HIVproducing THP-1 cells when the same ratio (1 :4) of competing nuclei
from THP-1 cells with restricted expression was added (Fig . 3, lane 5) . This nuclear
material would also inhibit LTR-directed transcription of nuclei from HIVinfected
Tcells but notHTLV1 LTRdirected transcription in HTLV1-infected T cells (data
not shown).
To determine whether this negative regulation of viral transcription in these cells
with restricted expression was at the level ofDNA binding complex formation, gel
mobility shift assays were performed using theenhancer-TAR region (-117 to +82)
of the HIV-1 LTR (Fig . 4) . Two concentrations of each nuclear extract were used .
Extracts from HIV-1-producing THP-1 cells (Fig . 4, lanes 4 and 5) and a tat-producing
mouse cell line (lanes 8 and 9) give the same complex formation, while the extract
from the restricted cell line (lanes 6 and 7) did not have any DNA binding in the
area where extracts from both the productively infected THP-1 cells or the tat-
producing cells bound the DNA. A second (lower) complex was found from both
extracts of productive and restricted cells, but not the tat-producing cells . Mixing
FIGURE 4.
￿
Gel mobility shift
analysis ofprotein binding from
infected THP-1 cells to HIV
LTR. A"P-labeled oligonucle-
otide spanning the enhancer-
TAR region (-117 to +82) of
the HIV-1 LTR was incubated
with two concentrations (5 and
10 wg) of nuclear extracts pre-
pared from various cells as de-
scribed in Materials and Meth-
ods . Lane 1, probe alone ; lanes
2 and 3, uninfected THP-1 ;
lanes 4 and 5, productively in-
fected (BP-1) THP-l ; lanes6and
7, THP-1 with restricted HIV-
1 expression ; lanes8and 9, tat-
producing murine cell line;
lanes 10 and 11, productively
infected (BP-1) THP-1 plus
uninfected THP-1 (4 :1 ratio);
lanes 12 and 13, productively
infected THP-1 plus THP-1
with restricted HIV -1 expression
(4 :1 ratio); lanes 14 and 15,
productively infected THP-1
plus tat-producing murine cell
line (4 :1 ratio) ; and lane 16,
productively infected THP-1
with excess cold probe .MIKOVITS ET AL .
￿
1713
an extract from uninfected THP-1 with an extract from productively infected cells
did not affect binding (Fig . 4, lanes 10 and 11). In contrast, when an extract from
cells with restricted expression was mixed withan extract from productively infected
cells, the binding of productive cell extract to the LTR (Fig. 4, lanes 12 and 13)
was eliminated, suggesting one mechanism of restricted HIV -1 expression was at
the level of initiation of transcription by blockingDNA binding complex formation
with the HIV-1 LTR. Thus, HIVexpression in cells with restricted expression may
be actively suppressed by someDNA binding factor. Such expression is not detect-
able in cells with latent viral infection (data not shown) .
Reactivation of Virusfrom Cultures with Latent Infection.
￿
Since THP-1 cells with la-
tent virus exhibited no detectable viral expression and did not negatively regulate
viral transcription, we asked if, using PCR, we could detect viral expression in the
cells with latent virus (Fig . 5) . Using primer pairs to the gag region, which has been
shown to be the most sensitive region forHIV detection (26), two latently infected
cultures (Fig. 5, lanes 3 and 4) showed no detectable viral RNA after 2 h (Fig. 5
A) or 24 h (Fig . 5 B) of gel exposure. For comparison, productively infected T cells
FIGURE 5 .
￿
PCR analysis ofRNA from infected THP-1 cells under various conditions ofRNA
isolated, as described in Materials and Methods, was amplified using gag primers. At the end
of 35 cycles, aliquots were hybridized to a 32P-end-labeled oligonucleotide probe spanning the
region between the primer pairs . PCR products were analyzed on a 20% polyacrylamide gel
using the gag probe. (a) Lane 1, uninfected H9 ; lane 2, HIVIIIB H9 ; lane 3, latent THP-1
ADA; lane 4, latent THP-1 BP-1; lane 5, latent THP-1 BP-1 ; lane 6, THP-1; lane 7, BP-1 HUT
78 ; lane 8, BP-1 THP-1; lane 9, restricted THP-1 BP-1 ; lane 10,THP-1; lane 11, restricted THP-1
LPS treated; lane 12, restricted THP-1 PMAtreated ; lane 13, productive THP-1 ; lane 14, latent
THP-1 ADA; lane 15, latent THP-1 ADAwith 5-azacytidine; lane 16, latent THP-1 BP-1 LPS ;
lane 17, latent THP-1 BP-1 with 5-azacytidine; lane 18, latent THP-1 BP-1 with 5-azacytidine
plus LPS . Results from 2-h exposure. (b) Same lanes 24 h after exposure .1714
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(lane 7), productively infected THP-1 (lane 8), and THP-1 with restricted expres-
sion (lane 9) are shown. We next studied under what conditions the virus could be
reactivated. Neither LPS (Fig. 5, lane 16) nor IUdR (Fig. 5, lane 17) could induce
viral expression from cells with latent virus. Since previous work has shown that
the HIVLTR stably transfected in fibroblasts was methylated (28), 5-azacytidine
was used and found to be an inducer of virus expression (Fig. 5 B, lane 18, or Fig.
2 B, lane 3), even after the virus was latent for 10 mo. We cannot be sure whether
the level of RNA is due to activation of a small population of cells or to a general
lowerleveloftranscription. However, sufficient amounts ofinfectious viruswere pro-
duced to get a massiveinfection ofthe T cells line, HUT102B2, within 10d oftrans-
mission (Fig. 2 B, lane 4). Electron micrographs of reactivated latent virus trans-
mitted into HUT-102B2 show typicalmorphological characteristicsofHIV assembly
and budding (Fig. 6).
Viral and Cellular Biology of Restrictedly and Latently HIV-infected THP-1.
￿
The mor-
phological, phenotypic, andfunctional characteristics ofTHP-1 cellswith restricted
and productive expression of HIV-1 were essentially the same as uninfected cells.
Phagocytosis ofyeast particles, accessory cell function forTcell activation, and de-
velopment ofanchoragedependence were all normal before and after PMA-induced
differentiation.
Since these cells were functionally normal, we next asked whether they were im-
munologically normal. As we had previously shown (15), IL-2-activated LGL can
recognize and lyse HIV-infected cells. Specific LGL-mediated cytotoxicity was ob-
served only on the HIV-1-producing THP-1 cells. IL-2 stimulation increased the
magnitudeofLGL-mediated cytotoxicity. No cytotoxicity was seenonthe cellswith
restricted HIV expression, suggestingthat such cells can avoid recognitionby specific
immune mechanisms.
The biological characteristics ofthe virus residing in these functionally and im-
munologically normal THP-1 cells were determined. T cellcytopathology was mea-
suredusingan assay where virus-producingcells causecytolysis ofMT-2 target cells
(Fig. 7 A). Using HIV-1-infected HUT-78 cells, 50°Io of the target cells are killed
by 100 cells, while all the cells are killed by 250 cells. Using the THP-1 cells with
restricted expression, 500 /c ofthe target cells arekilled by 200cells. This cell cytotox-
icity is blocked when azidothymidine (AZT) is added to the cultures, showing that
it is HIV mediated. The supernatant ofthese cells with restricted expression cannot
induce MT-2 cytotoxicity (Fig. 7 B), while those from cells productively infected
kill veryefficiently. Supernatant from irradiated cells with restricted expression will
nowkill MT-2. Consistent withthis is the observationthatTHP-1 cells with restricted
expression will not kill MT-2 cells when they are separated by a permeable barrier
(data not shown). Virus reactivated from latently infected THP-1 cells after 10 mo
ofculture was able to kill T cells as efficiently as virus released from continuously
productive cultures.
Discussion
An acute productive infection of THP-1 cells was established using HIV-1 and
HIV-2. Between days 14 and 21, 20-4070 of the cells contain antigens recognized
by anti-p24 and anti-gp 160/41. These data are consistent with published reports
using CD34' hematopoietic stem cells (29), fresh monocytes (9), and U937 (6, 7).MIKOVITS ET AL .
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Several weeks after infection of THP-1 cells by HIV, entire cultures spontaneously
became restricted in viral expression, while in the producer cultures, >90% of the
cells were viral antigenpositive. In some cases, spontaneousnonproducers have been
reported forTcells (3, 4) but not for monocytes. Two distinct types ofinfected cul-
tures with altered expression were identified in THP-1: (a) cells with restricted HIV
expression; and (b) cells with latent competent virus.
It is unlikely that these cultures arose due to selection of clonal variants, since
with infection at low MOI, no THP-1 cytotoxicity or loss of viability, growth, or
function was seen in infected cultures. However, it is not possible to rule out that
thecells with restricted orlatent infection were present from the firstday ofinfection
and eventually overgrew the other cells in the culture. While it is not possible to
determine how these cultures arose, their existence has important implications for
HIV viral persistence and pathology. Furthermore, in both types of restricted cul-
tures, cells couldbe induced toproducevirus after 10 mo inculture. Thus, the pheno-
type of these viral cultures was stable.
Characterization of these two types ofinfected monocytoid cultures has shown
that they are clearly different at the molecular and cellular level. In cells with re-
stricted HIV expression, there is a greatly reduced rate oftranscription and slower
accumulation ofviral RNA, asshown by nuclearrun-on, PCR, and Northern anal-
ysis. This is due at least in part to HIVspecific factor(s) present in the nucleus ofMIKOVITS ET AL.
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restrictedly infected cells that can negatively regulate transcription of productively
infected cells. Gel mobility shift analysis showed that formation of DNA binding
complexes associated with tat is eliminated by nuclear extracts of restrictedly in-
fected cells, suggesting that initiation oftranscription is being regulated. In addi-
tion, productionofgenomicviral RNA isbeing reducedin these restricted cellswith
a concomitant appearance ofa novel subgenomic 7.5-kb RNA (Fig. 2). This RNA
is not seen when the virus is then reinfected into T cells. In cells with latent virus,
viral expression and the ability to negatively regulate transcription ofproductively
infected cellswere not observed. By PCR analysis, noviral RNAwas found including
nefRNA (datanot shown), suggesting that nefdoes not serve as a negative regulator
in these cells. This is the first demonstration that HIV infection ofmonocytoid cells
can lead to latency at the molecular level.
In addition, the ability ofvarious agents to activate viral expression in these two
infectedcell types is distinct. In agreement with several others (30-33), we find var-
ious cytokine treatments, LPS, PMA, TNFa, and GM-CSF, can stimulate expres-
sion in restricted cells such that viral levels approach thatofa productive cell. How-
ever, noneofthese treatments stimulate detectableproduction from cellswithlatent
virus. The ability of5-azacytidine toreactivate virus productionsuggests that meth-
ylation is involved in the regulation ofHIV expression in these latently infectedcells.
Using a stably transfected LTR into fibroblasts, it has been previously shown that
methylation of HIV LTR sequences could occur (28).
Treatments that positively regulate HIV transcription can be mediated by cel-
lular factors such as NFKB (34, 35), and AP-1 (36) that bind to specific sequences
in theHIVLTR. In addition, thathas been postulated to mediate its effects through
cellular factors thatbind to the sequences responsive to thetransactivatingresponse
region (37). Viralfactors such as thenefgene product, which can repress HIV tran-
scription(38), andvpu, which affects viral release (39), could be important in estab-
lishingthese states ofviral suppression. In addition to the cytokines that upregulate
viralexpression, IFN-a has recentlybeen shownto restrict viralproduction in human
monocytes(40) and U-937 cells (7). It is clearthat multiple pathways regulate HIV
transcription, and that negative regulation ofviral expression in THP-1 cells prob-
ably involves viral and cellular factors.
The biological consequences of these types ofrestricted HIV expression may be
important in the pathogenesis ofthe disease. In the cells with restricted expression,
most ifnot all infectious virus produced is sequestered intracellularly. The cells even-
tually store sufficient virus to kill T cells as efficiently as productively infected T
cells, probably through cell-cell contact with the uninfected target. Suppression of
extracellular virus production and cell surface viral antigen expression allows the
monocyte with restricted expression to escape recognition and subsequent lysis by
the immune system, which is the fate ofproductively infected cells (15). In the cells
with latent infection, no virus is seen. Infectious virus can be activated and can
efficiently kill T cells even after being quiescent forlong periods oftime. From the
molecular and biological aspects, these two states are mechanistically and function-
ally different. Chronic low level expression is not a model for viral latency at the
molecular level, and viral latency has no low level expression (33). However, each
of these states provides at least one mechanism ofthe establishment of HIV viral
persistence. It would be important to determine the status ofviral latency in HIV171 8
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infected patients. Understanding these diverse interactions between HIV and mono-
cytes is important in understanding the nature of viral persistence and its relation-
ship to disease.
Summary
In THP-1 monocytoid cells infected with HIV, viral expression can be regulated
in several ways: (a) latency (no viral expression); (b) restricted expression (chronic
low-level viral expression with little or no detectable virus released); and (c) con-
tinuous production. In cells with restricted HIV expression, nuclear factor(s) were
found that blocked tat-associated DNA binding complex formation, suggesting that
initiation of transcription was negatively regulated. Also, viral particles were seen
budding into and accumulating within intracytoplasmic vacuoles with little virus
released, suggesting multiple levels of regulation. These cells with restricted expres-
sion had no detectable viral antigens on the cell surface and were not lysed by IL-2-
activated large granular lymphocytes. However, they could cause viral-mediated T
cell cytolysis in cell-cell assays, suggesting viral transmission through cell contact.
In addition, cellswith latent HIV were identified and could still produce infectious
virus after 5-azacytidine exposure 10 mo later. LPS and other treatments could in-
crease viral production in cells with restricted but not latent expression, suggesting
they occur by distinct mechanisms. These infected cells provide a reservoir for viral
transmission to uninfected T cellsthat itself is not detected by immune surveillance
mechanisms.
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Joost Oppenheim, Dan Longo, and Jeff Rossio for reviewing this manuscript.
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